Abstract
Background COVID-19 is now one of the leading causes of mortality amongst adults in the United States for the year 2020. Multiple epidemiological models have been built, often based on limited data, to understand the spread and impact of the pandemic. However, many geographic and local factors may have played an important role in higher morbidity and mortality in certain populations.
Objective The goal of this study was to develop machine learning models to understand the relative association of socioeconomic, demographic, travel, and health care characteristics of different states across the United States and COVID-19 mortality.
Methods Using multiple public data sets, 24 variables linked to COVID-19 disease were chosen to build the models. Two independent machine learning models using CatBoost regression and random forest were developed. SHAP feature importance and a Boruta algorithm were used to elucidate the relative importance of features on COVID-19 mortality in the United States.
Results Feature importances from both the categorical models, i.e., CatBoost and random forest consistently showed that a high population density, number of nursing homes, number of nursing home beds and foreign travel were strongest predictors of COVID-19 mortality. Percentage of African American amongst the population was also found to be of high importance in prediction of COVID-19 mortality whereas racial majority (primarily, Caucasian) was not. Both models fitted the data well with a training R2 of 0.99 and 0.88 respectively. The effect of median age,median income, climate and disease mitigation measures on COVID-19 related mortality remained unclear.
Conclusions COVID-19 policy making will need to take population density, pre-existing medical care and state travel policies into account. Our models identified and quantified the relative importance of each of these for mortality predictions using machine learning.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB approval not required.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data sources listed in supplemental content
